HopeStage
Back to all studies
CompletedNCT02502175

Opium Tincture Compared With Methadone for Opioid Use Treatment

About this title

Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder

Read the official source — NCT02502175
Medication studyIranAddiction
The study in practice

Understand this study

Listed locations
Moḩammadābād and 3 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 22, 2017
Recruitment status
Completed
Enrollment listed in the registry
204
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Iran
Age range
Not clearly listed
Official registry ID
NCT02502175
Official title
Show the full official title

Comparing Opium Tincture (OT) and Methadone for Medication-assisted Treatment of Opioid Use Disorder: A Randomized Double-blind Controlled Clinical Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Moḩammadābād · Sari · Isfahan

1 more locations
  • Shiraz

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Did this study involve medication?

Yes. The study involved medication, including opium and methadone.

Want to explore more studies?

Explore studies